JavaScript is a sprawling and ever-changing behemoth, and may be the single-most connective piece of web technology. From AI ...

NPM developer qix's account compromise potentially puts user funds at risk by compromising library dependencies used by ...

Replimune (REPL) stock plummets as report suggests FDA’s top regulator of cancer drugs intervened in rejecting its lead asset. Read more here.

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in refractory melanoma. Click to read.

A class action lawsuit was filed against Replimune Group ($REPL) by Levi & Korsinsky on July 24, 2025. The plaintiffs ...

NPM supply chain attack compromised 18 popular JavaScript packages, swapping crypto wallet addresses, but quick detection ...

Replimune Group, Inc. (REPL) Securities Class Action: The lawsuit is focused on the propriety of Replimune’s statements concerning data submitted to the FDA in support of its Biologics License ...

A JavaScript supply chain attack has delivered a crypto-clipper via 18 npm packages; Ledger’s CTO has warned ...

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 ...

ATLANTA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The lawsuit ...

NEW YORK - August 5, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit ...